New drug hopes to tame eye inflammation without infection

NCT ID NCT07218770

Ongoing Disease control Sponsor: Regeneron Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 16 times

Summary

This study tests an experimental drug called REGN7041 in people with active eye inflammation (uveitis) that is not caused by an infection. The main goal is to see if the drug is safe and tolerable, since this is the first time it's been tested in humans. Researchers will also measure how much drug gets into the blood and eye fluid, and whether the body makes antibodies against it. About 72 participants will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACTIVE NONINFECTIOUS UVEITIS AFFECTING THE POSTERIOR SEGMENT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Illinois Retina Associates

Oak Park, Illinois, 60304, United States
Retina Consultants of Texas

Katy, Texas, 77494, United States
Retina Consultants of Texas - Houston

Bellaire, Texas, 77401, United States
Retinal Consultants - Sacramento

Sacramento, California, 95825, United States
Tennessee Retina

Nashville, Tennessee, 37203, United States

Conditions

Explore the condition pages connected to this study.

ACTIVE NONINFECTIOUS UVEITIS AFFECTING THE POSTERIOR SEGMENT